Uncategorized

Johnson & Johnson (NYSE:JNJ)  today reported fourth-quarter earnings that beat the consensus forecast on Wall Street, but its sales numbers were slightly off amid declining medical device revenue. The New Brunswick, N.J.–based pharmaceutical, medical device and consumer products giant reported profits of $4.0 billion, or $1.50 per share, on sales of $20.7 billion for the three…

Chemical industry digital supply chain company Elemica (Wayne, Pa.) said recently that it has extended its offerings to the pharmaceutical industry. Pharma companies using Elemica solutions will now benefit from improved collaboration, visibility, quality management, traceability and speed of execution across their global supply chains, according to Elemica. The company has been building digital solutions…

Redesign Science and OpenEye Scientific announced that they have entered into a strategic partnership to integrate OpenEye’s Orion computational platform into Redesign’s drug-discovery platform. Santa Fe, N.M.-based OpenEye makes “cheminformatics” software for drug discovery, providing a reliable application programming interfaces (API) that customers use to build customizable programs and workflows. Its newly released Orion computational…

Mayo Clinic and W. L. Gore & Associates have announced a partnership to develop implantable cell therapies to treat debilitating conditions with no cure. The for-profit company, Avobis Bio, will combine a patient’s own stem cells with bioabsorbable scaffolds to stimulate the healing of perianal fistulas, painful tunneling wounds that affect patients with Crohn’s disease.…

GE Healthcare Life Sciences said today that it has entered into a strategic R&D and distribution partnership with Advanced Solutions Life Sciences — with a goal of personalized tissue regeneration. The partnership with Advanced Solutions Life Sciences is the latest in a string of investments and partnerships that GE Healthcare (NYSE:GE) has been making to further…